Upper limits on the MeV emission of Seyfert galaxies

por Maisack, M, Collmar, W, Barr, P, Blömen, H, Hermsen, W, Lichti, G G, McConnell, M, Schönfelder, V, Stacy, J G, Steinle, H, Williams, O R
Publicado 1994

P1231: ZILOVERTAMAB VEDOTIN (MK-2140) FOR THE TREATMENT OF NON-HODGKIN LYMPHOMA: THE PHASE 1 DOSE ESCALATION AND COHORT EXPANSION WAVELINE-001 STUDY OF AN ANTI-ROR1 ANTIBODY-DRUG C...

por Wang, M., Mei, M., Barr, P. M., Barrientos, J., de Vos, S., Furman, R., Patel, K., Thompson, P. A., Choi, M., Kallam, A., Zhu, Y., Chakraborty, S., Marinello, P., Spurgeon, S. E.
Publicado 2022

PB1878: CROSS-TRIAL ANALYSIS OF FIXED-DURATION IBRUTINIB (I) PLUS VENETOCLAX (V) VS FLUDARABINE (F), CYCLOPHOSPHAMIDE (C), AND RITUXIMAB (R) AS FIRST-LINE TREATMENT FOR CHRONIC LYM...

por Barrientos, J. C., Barr, P. M., Mato, A. R., Tam, C. S., Ghia, P., Moreno, C., Kay, N. E., Siddiqi, T., Szafer-Glusman, E., Zhou, C., Neumayr, L., Krigsfeld, G., Wierda, W. G., Shanafelt, T.
Publicado 2022

ESLAB papers

por Winkler, C M, Gehrels, N, Lund, N, Schönfelder, V, Ubertini, P, Barr, P, Breneol, C, Hansson, L, Nolan, J, Sternberg, J, Trams, N R, Winkler, C M, Schmidt, M, Dreger, F, Carli, R, Sarri, G, Timm, R, Mecke, G, Clausen, K
Publicado 1998

Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLL

por Brown, J R, Hillmen, P, O’Brien, S, Barrientos, J C, Reddy, N M, Coutre, S E, Tam, C S, Mulligan, S P, Jaeger, U, Barr, P M, Furman, R R, Kipps, T J, Cymbalista, F, Thornton, P, Caligaris-Cappio, F, Delgado, J, Montillo, M, DeVos, S, Moreno, C, Pagel, J M, Munir, T, Burger, J A, Chung, D, Lin, J, Gau, L, Chang, B, Cole, G, Hsu, E, James, D F, Byrd, J C
Publicado 2018